Health CanadaGeneral Alert
Archived - Important Safety Information Regarding Early Virologic Non-response i...
Published: October 17, 2003Recall ID: 25370Category: generalCountry: Canada
Product Description & Identification
Archived - Important Safety Information Regarding Early Virologic Non-response in Patients with HIV Infection Treated with 3TC® (lamivudine), Ziagen® (abacavir) and VireadTM (tenofovir) - GlaxoSmithKline Inc.
Additional Source Details
| Field | Value |
|---|---|
| N I D | 25370 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/archived-important-safety-information-regarding-early-virologic-non-response-patients |
| Title | Archived - Important Safety Information Regarding Early Virologic Non-response in Patients with HIV Infection Treated with 3TC® (lamivudine), Ziagen® (abacavir) and VireadTM (tenofovir) - GlaxoSmithKline Inc. |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2003-10-17 |
| Organization | Marketed health products |